Expanded Potential Stem Cell lines of pig and human cells established
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells. These stem cells have the features of the very first cells in the developing embryo, and can develop into any type of cell. The research from LKS Faculty of Medicine of The University of Hong Kong (HKUMed), the Wellcome Sanger Institute, and the Friedrich-Loeffler-Institut in Germany offers incredible potential for studying human development and regenerative medicine.
The study published in Nature Cell Biology today (3rd June) is the first time scientists have been able to derive stem cells from early pig embryos. Domestic pigs have great potential for biomedical research because of their genetic and anatomical similarities to humans, including comparable organ sizes. Being able to genetically-modify pig stem cells will also be beneficial for animal health and food production.
Stem cells have the ability to develop into other cell types, and existing stem cell lines are already extremely useful for research into development, disease and treatments. However, currently available types of stem cell lines have limitations, and until now it has also not been possible to create embryonic stem cells from pigs and many other farm animals.
“Scientists have been attempting to derive porcine embryonic stem cells for decades without much success. With our Expanded Potential Stem Cell technology, we have now successfully derived and characterised stem cells from porcine preimplantation embryos. We have also established similar human stem cells. Our study represents a significant advance in stem cell research.”
Professor Pentao Liu, the leader of the study from the School of Biomedical Sciences and Stem Cell and Regenerative Medicine Consortium, HKUMed, and previously of the Wellcome Sanger Institute
Since human EPSCs can produce large numbers of placenta cells – called trophoblasts – they offer new opportunities to investigate pregnancy complications such as pre-eclampsia and miscarriages.
EPSCs come from culturing cells from the earliest stage of development, when the fertilised egg has only divided into 4 or 8 cells and the cells retain some totipotency – the ability to produce all cell types.
“These EPSC stem cells possess developmental potency that is not generally seen in conventional embryonic or induced pluripotent stem cells. They have the potential to produce all embryonic and extra-embryonic cell lines – including those in the placenta and yolk sac, turning back the development clock to the very earliest cell type. These cells will enable researchers to study early embryonic development, miscarriage and developmental disorders.”
Dr Xuefui Gao, a first author on the paper from HKUMed, and previously from the Wellcome Sanger Institute
The first EPSCs were created in 2017, when the group targeted key molecular pathways during very early development in mice. At these very earliest embryonic developmental stages, mammalian species are very similar and the cells are like a blank sheet of paper. This study has shown that it is possible to use the same approach to create human EPSCs and also to establish EPSCs from pigs – mammals that had previously been elusive to stem cell researchers.
“Our porcine EPSCs isolated from pig embryos are the first well-characterized pig cell lines worldwide. EPSC’s great potential to develop into any type of cell provides important implications for developmental biology, regenerative medicine, organ transplantation, disease modelling, and screening for drugs.”
Dr Monika Nowak-Imialek, an author on the paper from the Friedrich-Loeffler-Institut (FLI) in Germany
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- Meso Numismatics Enters Into Binding LOI with Global Stem Cells Group Part of Overall Transaction with Lans Holdingson November 29, 2019 at 4:31 pm
Global is a premier stem cell company that specializes in cutting edge stem cell research, patient application and physician training. Global licenses its intellectual property and name to medical ...
- Stem Cells Center Set to Open Doors on Two Locations in New York Stateon November 29, 2019 at 10:20 am
The Stem Cells Center, a subsidiary of the Global Stem Cells Group (GSCG), has announced that it has signed an agreement with a New York doctor, bringing regenerative medicine treatments to more ...
- Targeted stem-cell attack could make transplants saferon November 29, 2019 at 7:37 am
Scientists are experimenting with ways to selectively target the body’s blood-making cells for destruction. Early studies in animals and people suggest that the approach could make blood stem-cell ...
- Functional maturation of human neural stem cells in a 3D bioengineered brain model enriched with fetal brain-derived matrixon November 29, 2019 at 2:22 am
Using developmental stage-sourced brain ECM in reproducible 3D bioengineered culture systems, we demonstrate enhanced functional differentiation of human induced neural stem cells (hiNSCs) into ...
- Stem Cell Media Market Competitive Research And Precise Outlook 2019 To 2025on November 28, 2019 at 10:40 am
Nov 28, 2019 (Market Insight Reports via COMTEX) -- The Stem Cell Media Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2019-2025. The Stem Cell Media Market report ...
- 33-year-old Charleston man needed a second stem cell transplant. He hopes this one works.on November 28, 2019 at 6:16 am
Russell's lymphoma, for example, required him to undergo three different chemotherapy regimens before he was considered in remission. Then, in 2017, doctors transplanted stem cells from Russell's own ...
- Researchers identify protein that governs human blood stem cell self-renewalon November 28, 2019 at 2:26 am
UCLA scientists have discovered a link between a protein and the ability of human blood stem cells to self-renew. In a study published today in the journal Nature, the team reports that activating the ...
- Stem cell therapy helps broken hearts heal in unexpected wayon November 27, 2019 at 1:58 pm
A study shows stem cell therapy helps hearts recover from a heart attack, although not for the biological reasons originally proposed two decades ago that today are the basis of ongoing clinical ...
- How stem cells help repair heartson November 27, 2019 at 11:05 am
Stem cells are being used to help heart attack victims, but we don’t really know what their impact is. The controversial use of stem cells to help patients recover from a heart attack may work, but ...
- Benefits of stem cell heart therapy may have nothing to do with stem cells, a study on mice suggestson November 27, 2019 at 10:08 am
For 15 years, scientists have put various stem cells into seriously ill patients’ hearts in hopes of regenerating injured muscle and boosting heart function. A new mouse study may finally debunk the ...
via Bing News